Rapid improvement of intracranial tuberculomas after addition of ofloxacin to first-line antituberculosis treatment

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 18, Issue 10, 1999, Pages 726-728

  Sermet Gaudelus, I ^a   Stambouli, F ^a   Abadie, V ^a   Goutieres F ^a   Lenoir, G ^a   Gendrel, D ^b   Gaillard, J L ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ETHAMBUTOL; ISONIAZID; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ABSCESS; ARTICLE; BRAIN; CASE REPORT; CENTRAL NERVOUS SYSTEM; DRUG PENETRATION; EMPYEMA; FEMALE; HUMAN; LYMPHADENOPATHY; MACROPHAGE; MEDIASTINUM LYMPH NODE; MENINGOENCEPHALITIS; MILIARY TUBERCULOSIS; OSTEOLYSIS; PRIORITY JOURNAL; SCALP; SCHOOL CHILD; SKULL; TUBERCULOMA;

EID: 0032699868     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050386     Document Type: Article

References (11)

1. 1. Leysen DC, Haemers A, Pattyn S: Mycobacteria and the new quinolones. Antimicrobial Agents and Chemotherapy (1989) 33:1-5
2. 2. Starke J, Correa A: Management of mycobacterial infection and disease in children. Pediatric Infectious Disease Journal (1995) 14:455-470
3. 3. American Thoracic Society: Treatment of tuberculosis and tuberculous infection in adults and children. American Journal of Respiratory Critical Care Medicine (1994) 149:1359-1374
4. 4. Burkhardt JE, Walterspiel JN, Schaad UB: Quinolone arthropathy in animals versus children. Clinical Infectious Diseases (1997) 25:1196-1204
5. 5. Hejazi N, Hassler W: Multiple intracranial tuberculomas with atypical response to tuberculostatic chemotherapy. Review of the literature and own experience. Acta Neurochirurgica (1997) 139:194-202
6. 6. Afghani B, Lieberman JM: Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review. Clinical Infectious Diseases (1994) 19:1092-1099
7. 7. Yew WW, Kwan SY, Ma WK, Khin MA, Chau PY: In-vitro activity of ofloxacin against Mycobacterium tuberculosis and its clinical efficacy in multiply resistant pulmonary tuberculosis. Journal of Antimicrobial Chemotherapy (1990) 26:227-236
8. 8. Kaplan JA, Krieff DM: Quinolones for the treatment and prophylaxis of tuberculosis. Annals of Pharmacotherapy (1996) 30:1020-1022
9. 9. Neuman M: Clinical pharmacokinetics of the newer antibacterial 4-quinolones. Clinical Pharmacokinetics (1988) 14:96-121
10. 10. Pioget JC, Wolff M, Singlas E, Laisne MJ, Clair B, Regnier B, Vachon F: Diffusion of ofloxacin into cerebrospinal fluid of patients with purulent meningitis or ventriculitis. Antimicrobial Agents and Chemotherapy (1989) 33, Supplement 6:933-936
11. 11. Schaad U, Salam AM, Aujard Y: Use of fluoroquinolones in pediatrics. Consensus report of an International Society of Chemotherapy Commission. Pediatric Infectious Disease Journal (1995) 14:1-9